These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 19252334)

  • 21. Estimating the glomerular filtration rate in obese adult patients for drug dosing.
    Pai MP
    Adv Chronic Kidney Dis; 2010 Sep; 17(5):e53-62. PubMed ID: 20727504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human renal function maturation: a quantitative description using weight and postmenstrual age.
    Rhodin MM; Anderson BJ; Peters AM; Coulthard MG; Wilkins B; Cole M; Chatelut E; Grubb A; Veal GJ; Keir MJ; Holford NH
    Pediatr Nephrol; 2009 Jan; 24(1):67-76. PubMed ID: 18846389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of simple allometric and maturation models for the prediction of morphine clearance in pediatrics.
    Mahmood I
    Drug Metabol Drug Interact; 2011; 26(2):71-7. PubMed ID: 21417797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism-based concepts of size and maturity in pharmacokinetics.
    Anderson BJ; Holford NH
    Annu Rev Pharmacol Toxicol; 2008; 48():303-32. PubMed ID: 17914927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of drug clearance in children 3 months and younger: an allometric approach.
    Mahmood I
    Drug Metabol Drug Interact; 2010; 25(1-4):25-34. PubMed ID: 21417791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.
    Knibbe CA; Zuideveld KP; Aarts LP; Kuks PF; Danhof M
    Br J Clin Pharmacol; 2005 Jun; 59(6):705-11. PubMed ID: 15948935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models.
    Mahmood I
    J Clin Pharmacol; 2016 Jun; 56(6):733-9. PubMed ID: 26437918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating renal function in children: a new GFR-model based on serum cystatin C and body cell mass.
    Andersen TB
    Dan Med J; 2012 Jul; 59(7):B4486. PubMed ID: 22759853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
    Pai MP
    Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should estimates of glomerular filtration rate and creatinine clearance be indexed to body surface area for drug dosing?
    Nix DE; Mayersohn M; Erstad BL
    Am J Health Syst Pharm; 2017 Nov; 74(21):1814-1819. PubMed ID: 28947625
    [No Abstract]   [Full Text] [Related]  

  • 33. Prediction of drug clearance in children.
    Foissac F; Bouazza N; Valade E; De Sousa Mendes M; Fauchet F; Benaboud S; Hirt D; Tréluyer JM; Urien S
    J Clin Pharmacol; 2015 Jul; 55(7):739-47. PubMed ID: 25721251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maturation and growth of renal function: dosing renally cleared drugs in children.
    Hayton WL
    AAPS PharmSci; 2000; 2(1):E3. PubMed ID: 11741219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.
    Bouwmeester NJ; Anderson BJ; Tibboel D; Holford NH
    Br J Anaesth; 2004 Feb; 92(2):208-17. PubMed ID: 14722170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Principles and clinical application of assessing alterations in renal elimination pathways.
    Tett SE; Kirkpatrick CM; Gross AS; McLachlan AJ
    Clin Pharmacokinet; 2003; 42(14):1193-211. PubMed ID: 14606929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of age and frailty with paracetamol conjugation in man.
    Wynne HA; Cope LH; Herd B; Rawlins MD; James OF; Woodhouse KW
    Age Ageing; 1990 Nov; 19(6):419-24. PubMed ID: 2285011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wide size dispersion and use of body composition and maturation improves the reliability of allometric exponent estimates.
    González-Sales M; Holford N; Bonnefois G; Desrochers J
    J Pharmacokinet Pharmacodyn; 2022 Apr; 49(2):151-165. PubMed ID: 34609707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.